Ms. Smith is a 52 y/o female with PMH significant for diabet…
Ms. Smith is a 52 y/o female with PMH significant for diabetes, diabetic neuropathy, CVA, and MI four years ago. She is being managed in the community by her psychiatry of two years. Over the course of the two years, Ms. Jane has trialed and failed two different atypical antipsychotics to manage her symptoms. What medication is considered first line for treatment-resistant schizophrenia?